VEGFA and neoplasm: Specifically, we have studied the effect of AZD5363 on the levels of pro‐angiogenic proteins VEGF and hypoxia‐inducible factor 1‐alpha (HIF‐1α) and the subsequent impact of any alteration on tumour vascularity and oxygenation.